Sulfonylureas
GLP1
Metformin
Insulin
SGLT2
100

What do all the sulfonylureas end in (like in the name)

-ide

100

Name a dual GLP-1/GIP med

Tirzepatide

100

This drug is considered first-line therapy for T2DM patients

Metformin

100

What patient population requires insulin for therapy

T1 diabetics

100

What other diseases can benefit from SGLT2 use

ASCVD, CKD, heart failure

200

What other type of drug does sulfonylureas commonly interact with

Antimicrobials

200

Name a non insulin/glucagon related MOA for why GLP-1s can help with diabetes

Slowed gastric emptying and enhancement of satiety
200

Name two enzymes metformin acts upon to cause its effects and say what it does

  • Mitochondrial Complex I Inhibition -> acute glucose lowering effects

  • mGPDH inhibition -> Alters cellular redox leading to increased NADH/NAD ratio -> decreased conversion of lactate and glycerol to glucose -> decreased gluconeogenesis

  • Activation of AMPK -> reduces fatty acid synthesis, inhibits hepatic gluconeogenesis, increases glucose uptake in skeletal muscle, and promotes fatty acid oxidation

200

What is the most significant adverse effect and what is a common side effect

Most significant: Hypoglycemia

Common: Weight gain

200

How does SGLT2 cause increased risk for UTI

More glucose in pee -> more nutrients for bacteria YUM!

300

What is the mechanism of sulfonylureas

Stimulate insulin secretion via binding to atp-sensitive K+ channels causing Ca influx and release of insulin

300

What is the most common side effect?

GI disturbances (nausea, vomiting, abdominal pain, etc)

300

What is the classification of metformin

Biguanide antihyperglycemic agent

300
What type of receptor is the insulin receptor

Tyrosine kinase receptor

300

How many days prior to surgery should SGLT2s be discontinued

3 days to prevent euglycemic DKA